Norwegian research breakthrough can solve CFS-mystery HOT OFF THE PRESS!!!
Norwegian research breakthrough can solve CFS-mystery
http://www.tv2.no/nyheter/innenriks...reakthrough-can-solve-cfsmystery-3615631.html
Here are my blogs and vlogs:
http://www.youtube.com/user/yourARTescortFRANKLY?feature=mhee
http://www.youtube.com/user/kaiserMECFS?feature=mhee
http://kaisermecfs.blogspot.com/
http://yourartescort.blogspot.com/
My friend from Norway just emailed this to me in Italy and I am rushing it to you all before it even hit the press.... let's cross our fingers and little toes...
Two oncologists in the city of Bergen in Norway have recently discovered a possible treatment for Chronic Fatigue Syndrome. The drug that they administered improved the condition of two out of three of the patients treated. Several patients were healed.
TV 2 has exclusive access to the research paper that came out in the medical journal PLOS one. Mella and his colleague, attending MD ystein Fluge, have completed a double-blind study on 30 Norwegian CFS-patients.
The results are sensational. Two out of three of the patients experienced major improvement, while some experienced a full recovery.
New status to CFS-patients
I addition to providing hope to millions of CFS-patients concerning treatment, the MDs are giving the patients, as a group, new status.
The two doctors say the results indicate that CFS is in fact a somatic decease.
"We think that CFS is an autoimmune decease. The immune system has a central role in this," they say to TV 2 News.
Attracts international attention
The discovery has already attracted international attention. However, the news wasnt released to the public until today, after the medical journal finally lifted the embargo.
Mella and Fluge presented their results as early as in May at a CFS-conference in London. At the conference, reporting restrictions were imposed upon the audience. Following the conference, the doctors have been contacted by several foreign doctors and researchers who attended the London-meeting.
Cancer-drug against CFS
The two Norwegians are the first two doctors in the world to have found that the cancer-drug Rituximab has very good effects upon CFS.
Each year the disease, which has an unknown etiology, ruins the lives of millions of people worldwide. In Norway alone it is estimated that 15.000 people have CFS.
A fortunate conjuncture
Professor Mella and attending MD Fluge have basically stumbled over what could become one of the biggest breakthroughs in the field of CFS.
A patient with Hodgkins lymphoma also had the diagnosis CFS. To fight the cancer, the patient was given amongst other treatments, the antibody Rituximab. After a few weeks the patients condition regarding CFS-symptoms suddenly improved.
Completely surprisingly, to both us and the patient, the CFS-symptoms were gone after six to eight weeks after the treatment, says Fluge.
First in the world
Through a so-called double blind study, the doctors have tested the drug which is normally used in cancer treatment on patients who had CFS. There was a total of 30 people in the study.
Half of the patients received saline, while the other half received Rituximab. No one knew who received which of these two, including the doctors or the nurses.
The group was split up by the pharmacist who drew lots. The drug and the saline containers were double bagged in red plastic. This was done so no one would see who got what, says Fluge.
In the group that received Rituximab, ten out of 15 had a significant positive effect. Nine of these had what the doctors characterize as a significant improvement.
Amongst those who received the placebo, only two had a measureable improvement. Only one of these two experienced what is characterized as a strong improvement.
In medical terms these results are considered to be good.
Amongst the patients that experienced effects from the drug, the transformations were enormous. They experienced a dramatic improvement in their symptoms. For some patients, the symptoms completely vanished.
The study did however show that the duration of the effect varies. Most patients have experienced relapse. Meanwhile, the doctors are now experimenting with continued treatments intended to maintain the effect. These treatments appear to be working.
Could transform lives
Some might consider administering a cancer drug to CFS patients to be irresponsible. However, Mella and Fluge point out that the CFS patients in some cases are so sick that they are chained to the bed most of the day.
Norwegian research breakthrough can solve CFS-mystery
http://www.tv2.no/nyheter/innenriks...reakthrough-can-solve-cfsmystery-3615631.html
Here are my blogs and vlogs:
http://www.youtube.com/user/yourARTescortFRANKLY?feature=mhee
http://www.youtube.com/user/kaiserMECFS?feature=mhee
http://kaisermecfs.blogspot.com/
http://yourartescort.blogspot.com/
My friend from Norway just emailed this to me in Italy and I am rushing it to you all before it even hit the press.... let's cross our fingers and little toes...
Two oncologists in the city of Bergen in Norway have recently discovered a possible treatment for Chronic Fatigue Syndrome. The drug that they administered improved the condition of two out of three of the patients treated. Several patients were healed.
TV 2 has exclusive access to the research paper that came out in the medical journal PLOS one. Mella and his colleague, attending MD ystein Fluge, have completed a double-blind study on 30 Norwegian CFS-patients.
The results are sensational. Two out of three of the patients experienced major improvement, while some experienced a full recovery.
New status to CFS-patients
I addition to providing hope to millions of CFS-patients concerning treatment, the MDs are giving the patients, as a group, new status.
The two doctors say the results indicate that CFS is in fact a somatic decease.
"We think that CFS is an autoimmune decease. The immune system has a central role in this," they say to TV 2 News.
Attracts international attention
The discovery has already attracted international attention. However, the news wasnt released to the public until today, after the medical journal finally lifted the embargo.
Mella and Fluge presented their results as early as in May at a CFS-conference in London. At the conference, reporting restrictions were imposed upon the audience. Following the conference, the doctors have been contacted by several foreign doctors and researchers who attended the London-meeting.
Cancer-drug against CFS
The two Norwegians are the first two doctors in the world to have found that the cancer-drug Rituximab has very good effects upon CFS.
Each year the disease, which has an unknown etiology, ruins the lives of millions of people worldwide. In Norway alone it is estimated that 15.000 people have CFS.
A fortunate conjuncture
Professor Mella and attending MD Fluge have basically stumbled over what could become one of the biggest breakthroughs in the field of CFS.
A patient with Hodgkins lymphoma also had the diagnosis CFS. To fight the cancer, the patient was given amongst other treatments, the antibody Rituximab. After a few weeks the patients condition regarding CFS-symptoms suddenly improved.
Completely surprisingly, to both us and the patient, the CFS-symptoms were gone after six to eight weeks after the treatment, says Fluge.
First in the world
Through a so-called double blind study, the doctors have tested the drug which is normally used in cancer treatment on patients who had CFS. There was a total of 30 people in the study.
Half of the patients received saline, while the other half received Rituximab. No one knew who received which of these two, including the doctors or the nurses.
The group was split up by the pharmacist who drew lots. The drug and the saline containers were double bagged in red plastic. This was done so no one would see who got what, says Fluge.
In the group that received Rituximab, ten out of 15 had a significant positive effect. Nine of these had what the doctors characterize as a significant improvement.
Amongst those who received the placebo, only two had a measureable improvement. Only one of these two experienced what is characterized as a strong improvement.
In medical terms these results are considered to be good.
Amongst the patients that experienced effects from the drug, the transformations were enormous. They experienced a dramatic improvement in their symptoms. For some patients, the symptoms completely vanished.
The study did however show that the duration of the effect varies. Most patients have experienced relapse. Meanwhile, the doctors are now experimenting with continued treatments intended to maintain the effect. These treatments appear to be working.
Could transform lives
Some might consider administering a cancer drug to CFS patients to be irresponsible. However, Mella and Fluge point out that the CFS patients in some cases are so sick that they are chained to the bed most of the day.
